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Abstract
Background: Fibroblasts, as connective tissue cells, are able to transform into another cell type
including smooth muscle cells. α1A-adrenergic receptor (α1A-AR) stimulation in rat-1 fibroblasts is
coupled to cAMP production. However, the significance of an increase in cAMP produced by α1A-
AR stimulation on proliferation, hypertrophy and differentiation in these cells is not known.
Results:  Activation of the α1A-AR in rat-1 fibroblasts by phenylephrine (PE) inhibited DNA
synthesis by 67% and blocked the re-entry of 81% of the cells into S phase of the cell cycle. This
cell cycle blockage was associated with hypertrophy characterized by an increase in protein
synthesis (64%) and cell size. Elevation of cAMP levels decreased both DNA and protein synthesis.
Inhibition of adenylyl cyclase or protein kinase A reversed the antiproliferative effect of cAMP
analogs but not PE; the hypertrophic effect of PE was also not altered. The functional response of
rat-1 cells to PE was accompanied by increased expression of cyclin-dependent kinase (Cdk)
inhibitors p27kip1 and p21cip1/waf1, which function as negative regulators of the cell cycle. Stimulation
of α1A-AR also upregulated the cell cycle regulatory proteins pRb, cyclin D1, Cdk 2, Cdk 4, and
proliferating cell nuclear antigen. The antiproliferative effect of PE was blocked by p27kip1 antisense
but not sense oligonucleotide. PE also promoted expression of smooth muscle cell differentiation
markers (smooth muscle alpha actin, caldesmon, and myosin heavy chain) as well as the muscle
development marker MyoD.
Conclusions: Stimulation of α1A-AR promotes cell cycle arrest, hypertrophy and differentiation
of rat-1 fibroblasts into smooth muscle-like cells and expression of negative cell cycle regulators by
a mechanism independent of the cAMP/PKA signaling pathway.
Background
Alpha1-adrenergic receptors (α1-ARs) are members of the
G-protein-coupled receptor superfamily. Both pharmaco-
logical and molecular cloning studies have indicated the
existence of multiple subtypes of α1-ARs including α1A/C-
AR, α1B-AR, and α1D-AR [1-4]. α1-ARs play a key role in a
variety of physiological processes, such as contraction of
vascular and cardiac muscle, contraction of the spleen,
liver glycogenesis, or melatonin secretion in the pineal
gland [3,4]. Activation of α1A-AR promotes hypertrophy
of cardiac myocytes [5,6]. Recently it has been shown that
all three subtypes of α1-AR are also expressed in rat aortic
adventitial fibroblasts and vascular smooth muscle cells
(SMC) [7] and their activation with norepinephrine
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stimulates migration, proliferation and protein synthesis
[8,9]. However, norepinephrine increased SMC hypertro-
phy, but not DNA synthesis, through α1A-AR stimulation
in uninjured aorta whereas norepinephrine stimulated
proliferation of adventitial fibroblasts through the α1B-AR
subtype [8].
Nonvascular fibroblasts, including cardiac fibroblasts
[7,10], generally do not express α1-AR and have been used
for stable transfection of different subtypes of α1-AR to
study their respective functions. However, a recent study
showed the expression of a functional α1A-AR in primary
tendon fibroblasts [11]. In rat-1 cells, a transformed cell
line from embryonic fibroblast, expressing different sub-
types of α1-AR, phenylephrine (PE), an α1-AR agonist,
activates phospholipase D and releases arachidonic acid
[12]. However, unlike SMC, activation of α1-ARs in rat-1
cells also increases cAMP levels and PKA activity [12]. α1A-
AR is more efficiently coupled to phospholipase D activa-
tion, arachidonic acid release and cAMP than α1B-AR or
α1D-AR in these cells [12]. Activation of α1A-AR expressed
in COS-7 and HeLa cells [13] and α1B-AR or α1D-AR in
COS and CHO cells [14] also increase cAMP levels. In
HepG2 and M12 cells expressing α1B-AR, PE causes cell
scattering and inhibits proliferation through activation of
MAP kinases [15].
The family of connective tissue cells includes fibroblasts,
cartilage cells, bone cells, fat cells and smooth muscle
cells. Fibroblasts seem to be able to transform into any of
other members of the family – in some cases reversibly –
although it is not clear whether this is a property of a sin-
gle type of fibroblast that is pluripotent or of a mixture of
distinct types of fibroblasts with more restricted poten-
tials. These transformations of connective tissue cell type
are regulated by the composition of the surrounding
extracellular matrix, by cell shape, and by hormones and
growth factors [16]. Heterologous expression of α1A-ARs
in CHO cells inhibits basal and growth factor-stimulated
DNA synthesis, in contrast to the α1D-AR [17]. A recent
study in the same model has reported cAMP as the medi-
ator of the antiproliferative effect of α1A-AR stimulation
[18]. Therefore, it is possible that activation of α1A-AR
with PE in rat-1 cells affects their growth and/or differen-
tiation status. To test this hypothesis, we have investigated
the effect of PE and cAMP modulators on proliferation,
growth and morphology in rat-1 cells expressing α1A-ARs.
Moreover, we have examined the effect of PE and cAMP
modulators on the expression of cell cycle regulators and
muscle cell markers, because of the ability of fibroblasts to
differentiate into myofibroblasts. Our results show that
activation of α1A-ARs in rat-1 cells exerts profound effects
promoting hypertrophy and expression of specific
smooth muscle cell markers. We also show here that α1A-
AR-induced cessation of DNA synthesis is independent of
cAMP and involves the expression of cyclin-dependent
kinase (Cdk) inhibitor, p27kip1.
Results
Stimulation of α1A-AR inhibits DNA synthesis at the G1/S 
checkpoint of the cell cycle in rat-1 fibroblasts
Rat-1 fibroblasts stably transfected with α1A-AR expressed
288 ± 2 fmol/mg protein of receptors [12]. Cells at 80%
confluency were serum-deprived for 48 h in DMEM and
then incubated with PE (2, 5 and 10 µM) for different
periods prior to the addition of [3H]thymidine. PE
decreased basal [3H]thymidine incorporation in a concen-
tration-dependent manner with a maximum effect at 10
µM PE (Fig 1A). Reduction of basal DNA synthesis was
significant after 12 h of treatment with a maximum effect
at 18 h of incubation with PE (> 65% decrease) (Fig 1B).
Rat-1 fibroblasts stably transfected with α1A-AR incorpo-
rate [3H]thymidine in DNA in a time-dependent manner
(from 6 to 24 h), even after 48 h of serum-deprivation (Fig
1B).
To determine whether PE at different concentrations
delays the re-entry of rat-1 cells into the cell cycle, we
examined the kinetics of cell cycle re-entry. Flow cytome-
try studies showed that incubation of the rat-1 cells with
2, 5, and 10 µM PE resulted in inhibition of the re-entry of
83, 81, or 85%, respectively, of the cell population into
the S phase of the cell cycle (Table 1). Therefore, stimula-
tion of α1A-AR inhibits DNA synthesis at the G1/S check-
point in rat-1 fibroblasts.
Stimulation of α1A-AR increases protein synthesis and 
promotes hypertrophy in rat-1 fibroblasts
Stimulation of α1-ARs in vascular smooth muscle cells
[19] and in adult rat ventricular myocytes [8] increases
hypertrophy and protein synthesis. However, the α1-AR
subtype mediating these effects is not known. Exposure to
5 µM PE for 18 h increased [3H]leucine incorporation by
64% (Fig 2B) and decreased basal [3H]thymidine uptake
(Fig 2A), as shown earlier in Fig 1. These effects were
blocked by prazosin (PRZ, 100 nM), an α1-AR antagonist.
Propranolol (2 µM), a β-AR antagonist (Fig 2A,B), or
yohimbine (1 µM), an α2-AR antagonist (data not
shown), had no effect on the decrease in basal [3H]thymi-
dine or the increase in [3H]leucine incorporation in rat-1
cells caused by exposure to PE. These results show that PE
stimulates protein synthesis and inhibits DNA synthesis
in rat-1 cells through activation of α1A-ARs. The hypertro-
phy index, an indicator of cellular hypertrophy, is defined
as the ratio of protein synthesis ([3H]leucine incorpora-
tion) to DNA synthesis ([3H]thymidine incorporation)
[20]. At 18 h, this ratio was 4.4 fold as high in PE-treated
cells (index = 0.22) than in control cells (index = 0.05, n
= 6), indicating that PE promotes rat-1 cell hypertrophy.BMC Cell Biology 2004, 5:47 http://www.biomedcentral.com/1471-2121/5/47
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Effect of PE on [3H]thymidine incorporation in rat-1 cells Figure 1
Effect of PE on [3H]thymidine incorporation in rat-1 cells. Cells were grown in 24-well plates in DMEM containing 10% FBS at 
a density of 150,000 cells/well until they reached 80–90% confluency, and then serum-deprived for 48 h in DMEM. A, Cells 
were treated with different concentrations of PE (2, 5, and 10 µM) for 18 h prior to the addition of [3H]thymidine (0.50 µCi/
ml) for the last 4 h. B, Cells were treated with PE for different incubation periods prior to the addition of [3H]thymidine (0.50 
µCi/ml). Cells were incubated with [3H]thymidine for the last 4 h and thymidine incorporation was determined as described in 
Methods. Data are expressed as dpm of [3H]thymidine incorporated in DNA per well. Values are the mean ± S.E. of six inde-
pendent experiments performed in quadruplicates on different batches of cells. * Values significantly different from vehicle, p < 
.05.
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Protein synthesis elicited by α1-AR stimulation was time-
dependent and remained significant from 6 to 72 h of
exposure with PE (Fig 3A). EGF and cAMP have opposite
effects on rat-1 fibroblasts proliferation [21,22]. There-
fore, we tested the effect of EGF and forskolin (FN), an
activator of adenylyl cyclase [12], on protein and DNA
synthesis. EGF (30 ng/ml) slightly increased, whereas FN
decreased, [3H]leucine incorporation at 6, 18, 48 and 72
h (Fig 3A). Surprisingly, PE was a better activator of pro-
tein synthesis than EGF. In contrast, EGF increased
[3H]thymidine incorporation by 272% (Fig 3B), an effect
blocked by FN and the cAMP analog, 8-cpt-cAMP, as well
as by PE.
PE inhibits DNA synthesis and promotes hypertrophy by a 
mechanism independent of cAMP
Previously, we have shown that PE induces cAMP accu-
mulation in rat-1 cells [12]. It is also known that cAMP-
dependent PKA-mediated inhibition of cell division is
due to blockade of growth factor-stimulated cell cycle pro-
gression from G1 to S phase [23]. Therefore, to determine
whether cAMP mediates the antiproliferative effect of PE,
we examined the effect of FN (0.1–10 µM) and 8-cpt-
cAMP (5–20 µM) and of FN and PE on DNA synthesis in
the presence and absence of adenylyl cyclase and PKA
inhibitors. FN and 8-cpt-cAMP inhibited [3H]thymidine
incorporation to the same extent as PE (Fig 4A). The FN
but not the PE-induced decrease in [3H]thymidine incor-
poration was blunted by the selective inhibitor of adeny-
lyl cyclase SQ 22536 (Fig 4B) and by the P-site inhibitors
of adenylyl cyclase 2',5'dideoxyadenosine, and 2'-deoxya-
denosine 3'-monophosphate (5 µM each-data not
shown). The selectivity of cAMP modulators, FN, 8-cpt-
cAMP and SQ 22536 has been tested previously in rat-1
fibroblasts [12]. To further determine the contribution of
cAMP pathway, rat-1 cells were transfected with πLXX-PKI
[1-31], a vector that expresses the PKA inhibitor, PKI
[23,24]. Transfection with PKI reversed the inhibitory
effect of FN, but not that of PE, on [3H]thymidine incor-
poration in rat-1 cells (Fig 4C). These observations indi-
cate that cAMP and PKA do not mediate the PE-induced
inhibition of DNA synthesis.
The antiproliferative effect of PE, FN and 8-cpt-cAMP
could be the result of cell loss due to a cytotoxicity. How-
ever, the trypan blue exclusion test and LDH assay showed
that more than 90% of cells were viable (Table 2) and less
than 1% of the cells were found in the supernatant, indi-
cating very little cell loss.
Morphological change elicited by α1A-AR stimulation and 
by cAMP in rat-1 cells
Although both PE and FN inhibited DNA synthesis in rat-
1 cells, they produced different effects on cell morphol-
ogy. PE increased, whereas FN decreased, the apparent
size of rat-1 cells as shown in Fig 5. Prazosin (100 nM), an
α1-AR antagonist, reversed the shape change produced by
PE. To determine if PE-induced cell cycle arrest and hyper-
trophy of rat-1 fibroblasts is also independent of cAMP,
we preincubated the cells with SQ22536 (25 µM) and
then treated them with PE (5 µM) or FN (1 µM) for differ-
ent time periods. SQ22536 reversed the morphological
changes produced by FN and restored the normal fibrob-
last shape, whereas it enhanced the effect of PE, i.e. the
cells became more hypertrophic.
p27kip1 mediates PE-induced inhibition of DNA synthesis
Cyclin-dependent kinase (cdk) inhibitors p27kip1  and
p21cip1/waf1 play an important role in cell-cycle regulation
[25,26]. High levels of p27kip1 and p21cip1/waf1 in quiescent
(G0) cells decline upon induction of mitogenesis [27].
This decrease in Cdk inhibitors appears to be critical in
enabling cell cycle entry. Western blot analysis showed
that α1A-AR stimulation increased the expression levels of
p27kip1 (642% of control at 48 h) and p21cip1/waf1 (935%
of control at 48 h) (Fig. 6A). The protein levels remained
elevated for 48 h, with levels of p27kip1 reaching 389% of
control at 18 h of incubation and remaining elevated for
up to 48 h. This increase was concomitant with the inhib-
itory effect of PE on DNA synthesis, which was also maxi-
mal at 18 h of incubation. PE increased the expression of
p27kip1 (552% of control at 24 h) more efficiently than
p21cip1/waf1(87% of control at 24 h) suggesting a greater
contribution of p27kip1 to PE-induced cell cycle arrest and
a delayed induction of p21cip1/waf1. Retinoblastoma
Table 1: Effect of PE on cell cycle phases.
Treatment G0/G1 phase S phase G2/M phase % inhibition (S)
vehicle 9269 ± 0.5 319.5 ± 13.5 238.5 ± 23.5 0 %
2 µM PE 9770 ± 9.0 54.0 ± 2.0 125 ± 21.0 83%
5 µM PE 9699 ± 29.0 59.0 ± 4.0 170 ± 11.0 81%
10 µM PE 9761.5 ± 89.5 47.5 ± 13.5 110.5 ± 39.5 85%
Cells were subjected to flow cytometric DNA analysis as described in Methods. Different concentrations of PE inhibited the re-entry of the cell 
population into S phase of the cell cycle. Data show the number of cells in each phase of the cell cycle. Values are the mean ± S.E. of three 
independent experiments performed in duplicate on different batches of cells (Total events per cycle is 10,000 cells).BMC Cell Biology 2004, 5:47 http://www.biomedcentral.com/1471-2121/5/47
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Stimulation of α1A-AR mediates the effect of PE on DNA and protein synthesis Figure 2
Stimulation of α1A-AR mediates the effect of PE on DNA and protein synthesis. A, Effect of prazosin (α1-AR antag-
onist) and propranolol (β-AR antagonist) on PE-induced inhibition of DNA synthesis. Cells were treated with prazosin and/or 
propranolol for 30 min before the addition of 5 µM PE for 18 h. [3H]thymidine incorporation was measured as described in 
Methods. Data are expressed as dpm of [3H]thymidine incorporated per well. Values are the mean ± S.E. of three independent 
experiments performed in quadruplicates on different batches of cells. * Value significantly different from the corresponding 
value obtained without PE treatment, p < .05. B, Effect of prazosin and propranolol on PE-induced increase in protein synthesis. 
Experimental conditions were similar as described in A. [3H]leucine incorporation was measured as described in Methods. 
Data are expressed as dpm of [3H]leucine incorporated per well. Values are the mean ± S.E of three independent experiments 
performed in quadruplicates on different batches of cells. * Value significantly different from the corresponding value obtained 
without PE treatment, p < .05.
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Effect of PE, cAMP-elevating agents and EGF on protein and DNA synthesis Figure 3
Effect of PE, cAMP-elevating agents and EGF on protein and DNA synthesis. A, Cells were treated with 5 µM PE, 1 
µM forskolin (FN) and 30 ng/ml EGF for different periods. [3H]leucine incorporation was measured as described in Methods. 
Data are expressed as dpm of [3H]leucine incorporated per well. Values are the mean ± S.E. of three independent experiments 
performed in sextuplicates. * Values significantly different from vehicle, p < .05. B, Effect of FN, 8-cpt-cAMP and PE on EGF-
induced [3H]thymidine incorporation. Cells were preincubated with FN (1 µM), 8-cpt-cAMP (5 µM) and PE (5 µM) for 1 h. 
Cells were then treated with EGF (30 ng/ml) for 18 h. Incorporation of [3H]thymidine into rat-1 fibroblasts was determined as 
described in Methods. Data are expressed as dpm of [3H]thymidine incorporated per well. Values are the mean ± S.E. of three 
independent experiments performed in duplicate in different batches of cells. * Value significantly different from vehicle, p < 
.05. § Value significantly different from the corresponding value obtained without treatment by FN, cpt-cAMP or PE, p < .05.
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Effect of PE and cAMP-elevating agents, FN and 8-cpt-cAMP, on DNA synthesis Figure 4
Effect of PE and cAMP-elevating agents, FN and 8-cpt-cAMP, on DNA synthesis. Cells were serum-deprived for 2 
days. A, Cells were treated with PE (5 µM), FN (0.1, 1, and 10 µM), and 8-cpt-cAMP (5, 10, and 20 µM) for 18 h. Incorporation 
of [3H]thymidine into rat-1 fibroblasts was determined as described in Methods. Data are expressed as dpm of [3H]thymidine 
incorporated per well. Values are the mean ± S.E. of three independent experiments performed in sextuplicates in different 
batches of cells. * Value significantly different from vehicle, p < .05. B, Effect of inhibitors of adenylyl cyclase inhibition on PE and 
cAMP-elevating agents. Cells were pre-incubated with SQ22536 (25 µM), an specific adenylyl cyclase inhibitor for 1 h. Cells 
were then treated with 5 µM PE and/or 1 µM FN for 18 h. [3H]thymidine incorporation was determined as described in Meth-
ods. Values are the mean ± S.E. of three independent experiments performed in quadruplicates on different batches of cells. 
Data are expressed as dpm of [3H]thymidine incorporated per well. * Value significantly different from the corresponding vehi-
cle, p < .05. § value significantly different from that obtained in the presence of agonist alone, p < .05. C, Effect of transfection 
of πLXX-PKI [1-31] on PE-induced inhibition of DNA synthesis. Preconfluent cells were transiently transfected with πLXX-PKI 
[1-31], a plasmid encoding for the protein kinase inhibitor, (PKI), using Lipofectamine Plus transfection reagent according to the 
manufacturer's protocol (Life Technologies). Cells were cultured in serum-free DMEM for 24 h and then treated with 5 µM PE 
and/or 1 µM FN. Cells were assayed for [3H]thymidine incorporation 48 h post transfection as described in Methods. Data are 
expressed as dpm of [3H]thymidine incorporated per well. Values are the mean ± S.E. of three independent experiments per-
formed on different batches of cells. * Value significantly different from the corresponding vehicle, p < .05. § value significantly 
different from that obtained in the presence of agonist alone, p < .05.
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protein (pRb) hyperphosphorylation and subsequent
release of E2F is required for cell cycle progression [28].
However,  α-AR stimulation of neonatal myocytes has
been shown to induce pRb hyperphosphorylation with-
out induction of cell proliferation [29]. Our results dem-
onstrate that PE promotes an early increase in pRb levels
(607% of control at 6 h) in rat-1 cells (Fig 6C), associated
with a decrease in DNA synthesis (Fig 1B). The nuclear
envelope proteins lamin A and C, used as control, were
not altered by PE treatment (Fig 6D).
In VSMC, p27kip1 level is a critical determinant of the cell
response, hyperplasia vs. hypertrophy, to angiotensin II
and other growth factors [20]. We postulated that the
response of rat-1 cells to PE was mediated by p27kip1. PE
upregulates the expression of p27kip1 at 18 h of treatment
in rat-1 cells at all concentrations (Fig 7A). We therefore
explored further the role of p27kip1 in modulating the anti-
proliferative response of rat-1 cells to PE by transfecting
these cells with p27kip1 antisense and sense ODN. p27kip1
antisense (102% of control), but not sense ODN (347%
of vehicle vs. 338% for PE alone), diminished p27kip1 level
(Fig 7B) and blocked the antiproliferative effect of PE in
rat-1 cells (Fig 7C). These observations suggest that PE-
induced inhibition of DNA synthesis is mediated by
p27kip1.
PE increases the expression of cyclin D1, proliferating cell 
nuclear antigen (PCNA), Cdk2 and Cdk4 in rat-1 cells
We next investigated the effect of PE on several cell cycle
proteins important for G1/S phase progression. Fig. 8
shows that treatment of serum-deprived rat-1 cells with PE
increased the levels of cyclin D1 (548% of control at 24
h), PCNA (158% of control at 24 h), and Cdk2 (236% of
control at 24 h) in a time-dependent manner. The levels
of nuclear envelope proteins lamin A and C, were not
altered. These results are unexpected since PE promotes
cell cycle arrest at G1/S checkpoint (Table 1). However, the
up-regulation of p27kip1 seems to be sufficient to block
cell cycle entry into S phase and DNA synthesis. Surpris-
ingly, we also observed an increase in the protein levels of
Cdk4 (280% of control at 24 h), which normally do not
change even during mitogenic stimulation.
PE increases expression of specific smooth muscle 
differentiation markers as well as MyoD
Cell cycle arrest is closely coupled to muscle cell differen-
tiation and is required for activation of muscle cell specific
gene expression [16]. Since stimulation of α1A ARs pro-
moted a change in morphology associated with hypertro-
phy, we examined the effect of PE on expression of the
specific smooth muscle cell markers, α-smooth muscle
actin (SMα actin), caldesmon and myosin heavy chain
(SM-MHC) [30]. The smooth muscle markers were not
expressed in serum-deprived rat-1 cells (Fig 9A,C).
Stimulation of α1A ARs with PE (5 µM) promoted a time-
dependent increase in the levels of SMα actin (695% of
control at 24 h) (Fig 9A), caldesmon (284% of control at
24 h) (Fig 9B) and SM-MHC (445% of control at 24 h)
(Fig 9C) as shown by Western blot analysis We also inves-
tigated the expression of MyoD, a helix-loop-helix protein
that plays an important role in the regulation of muscle
development [31]. Western blot analysis showed that PE
also increased the expression of MyoD in a time-depend-
ent manner (457% of control at 24 h), further supporting
the evidence that stimulation of α1A AR induces differenti-
ation of rat-1 fibroblasts into muscle-like cells, which is
closely coordinated with cell cycle arrest (Fig 9D). The
expression of vimentin, an intermediate filament protein
used as a control, was not altered by treatment with PE
(Fig 9E). The α1A AR stimulation of smooth muscle differ-
entiation markers was independent of cAMP because FN
did not increase the expression of SMα actin, caldesmon
or SM-MHC (Fig 10A,C). MyoD expression was not
altered by FN (Fig 10D). The level of vimentin expression
was not altered by PE or FN (Bar Graph). Together, these
data demonstrate that stimulation of α1AARs increases
expression of smooth muscle markers and MyoD in rat-1
cells, independently of cAMP.
Table 2: Effect of PE and cAMP elevating agents on viability of rat-1 fibroblasts using the hemocytometer trypan blue method.
Treatment Total number of cells Blue cells % of viability
Vehicle 78 8 90%
5 µM PE 142 10 92%
10 µM PE 87 12 86%
10 µM FN 78 8 90%
20 µM 8-cpt-cAMP 84 4 96%
20 µM 8-Br-cAMP 66 2 97%
Cells were incubated for 18 h with PE (5 and 10 µM), forskolin (FN), 8-cpt-cAMP and 8-Br-cAMP. The percentage of viable cells was calculated. 
Values are representative of five different experiments.BMC Cell Biology 2004, 5:47 http://www.biomedcentral.com/1471-2121/5/47
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Discussion
This study is the first demonstration of the ability of an
α1A-AR subtype to promote differentiation of a fibroblast
into a SMC/myocyte-like cell. Further, it demonstrates
that α1A-AR-induced cell cycle arrest and hypertrophy as
well as differentiation is mediated through a mechanism
dependent upon the increased expression of the critical
cell cycle protein p27kip1 and selective smooth muscle
markers.
Stimulation of α1A-ARs promotes hypertrophy of cardiac
myocytes [6]. Norepinephrine increases SMC hypertro-
phy, but not cell proliferation, through α1A-AR stimula-
tion in uninjured aorta [8]. In HepG2 and M12 cells
transfected with α1A-AR, PE stimulates cell scattering and
inhibition of proliferation [15]. Similar observations have
been made in CHO cells expressing α1A-ARs [17,18]. In
the present study, PE inhibited cell proliferation,
promoted hypertrophy and differentiation through
Effect of prazosin and SQ22536 on PE-and FN-induced morphological change in rat-1 cells Figure 5
Effect of prazosin and SQ22536 on PE-and FN-induced morphological change in rat-1 cells. Preconfluent, serum-
deprived cells were either stimulated with 5 µM PE and/or 1 µM FN for different periods of time (Fig 5B) and/or pretreated for 
30 min with 100 nM prazosin (Fig 5A) or 25 µM SQ22536 (Fig 5C), and then further incubated with 5 µM PE and/or 1 µM FN 
for 24 h. Morphological studies were performed as described in Methods. The same morphological patterns were obtained in 
three different experiments.BMC Cell Biology 2004, 5:47 http://www.biomedcentral.com/1471-2121/5/47
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Effect of PE on the expression of cell cycle regulators, p27kip1, p21ip1/waf1 and pRB Figure 6
Effect of PE on the expression of cell cycle regulators, p27kip1, p21ip1/waf1 and pRB. Preconfluent, serum-deprived 
cells were incubated with PE (5 µM) or vehicle for up to 48 h. Expression of cell cycle regulators was determined by Western 
blot analysis of whole cell lysates as described in Methods. The panels are representative Western blots showing the effect of 
PE on the expression of p27kip1 (A), p21cip1/waf1 (B), pRb (C), and lamin A/C (D) protein levels respectively. Percentages repre-
senting the quantitation of protein bands by densitometric analysis of blots obtained from three different experiments are indi-
cated on top of each immunoblot.
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Effect of PE on p27kip1 level and effect of p27kip1 antisense oligonucleotides on PE-induced inhibition of DNA synthesis Figure 7
Effect of PE on p27kip1 level and effect of p27kip1 antisense oligonucleotides on PE-induced inhibition of DNA 
synthesis. A, Preconfluent rat-1 cells were stimulated with 2, 5, and 10 µM PE for 18 h. Total cell lysates were subjected to 
Western blot analysis as described in Methods. Percentages representing the quantitation of protein bands by densitometric 
analysis of blots obtained from three different experiments are indicated on top of each immunoblot. B, Representative West-
ern blot showing the effect of p27kip1 antisense and sense oligonucleotides treatment on PE-induced increase in p27kip1 protein 
level. Cells were transiently transfected with p27kip antisense or sense oligonucleotide for 48 h using Oligofectamine™ Reagent 
according to the manufacturer's instruction (Invitrogen). C, Transfected cells as in B were serum-starved for 24 h and then 
treated with 5 µM PE. Thymidine uptake was measured as described in Methods 48 h post-transfection. Data are expressed as 
the percent decrease in [3H]thymidine uptake above the basal value obtained in unstimulated cells. Values are the mean ± S.E 
of three independent experiments performed in different batches of cells. * Value significantly different from the corresponding 
vehicle, p < .05.
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Effect of PE on the expression of cyclin D1, PCNA Cdk 2, and Cdk 4 Figure 8
Effect of PE on the expression of cyclin D1, PCNA Cdk 2, and Cdk 4. Preconfluent, serum-deprived cells were stimu-
lated with PE (5 µM) for 6, 12, 24 and 48 h. Cell-cycle regulators expression was determined by Western blot analysis of whole 
cell lysates as described in Methods. The bar graph represents quantitation of protein bands by densitometric analysis of blots 
obtained from three different experiments. * Value significantly different from the corresponding vehicle, p < .05.
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Time course of the effect of PE on the expression of the smooth muscle differentiation markers and MyoD Figure 9
Time course of the effect of PE on the expression of the smooth muscle differentiation markers and MyoD. 
Preconfluent, serum-deprived fibroblasts were stimulated with PE (5 µM) for up to 48 h. The protein expression of smooth 
muscle differentiation markers and MyoD was determined by Western blot analysis of whole cell lysates as described in Meth-
ods. A, smooth muscle α actin (SMα actin). B, caldesmon. C, smooth muscle myosin heavy chain (SM-MHC). D, MyoD, E, 
vimentin. VSMC lysate is shown as a positive control. Percentages representing the quantitation of protein bands by densito-
metric analysis of blots obtained from three different experiments are indicated on top of each immunoblot.
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Effect of PE and FN on the expression of smooth muscle differentiation markers and MyoD Figure 10
Effect of PE and FN on the expression of smooth muscle differentiation markers and MyoD. Preconfluent, serum-
deprived fibroblasts were stimulated with either PE (5 µM) or FN (1 µM) for up to 48 h. Expression of markers was deter-
mined by Western blot analysis of whole cell lysates as described in Methods. A, smooth muscle α actin (SMα actin). B, caldes-
mon. C, smooth muscle myosin heavy chain (SM-MHC). D, MyoD. VSMC lysate is shown as a positive control in panel A, B, C 
and D. The bar graph represents quantitation of protein bands by densitometric analysis of blots obtained from three different 
experiments. * Value significantly higher than the corresponding vehicle, p < .05.
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stimulation of α1A-ARs in rat-1 cells expressing this sub-
type. Analysis of the effect of α1A-AR stimulation on cell
cycle progression revealed that it inhibits the re-entry of
cells from G0/G1 into the S phase of the cell cycle.
Next we attempted to define the mechanism mediating
α1A-AR-induced cell cycle arrest, hypertrophy and differ-
entiation of rat-1 cells. Previous studies have shown that
in rat 1-cells expressing α1A-ARs, PE promotes increase in
cAMP accumulation and PKA activation [12]. Since cAMP
has been reported to inhibit growth in various cell types,
including cells of fibroblastic origin [32], it seemed
possible that cAMP mediates the inhibitory effect of PE on
rat-1 cells proliferation. Stable cAMP analogs or adenylyl
cyclase activation promoted cell cycle arrest similar to α1A-
AR stimulation. However, activation of the cAMP/PKA
pathway did not promote hypertrophy or differentiation
of rat-1 cells. Moreover, inhibition of cAMP/PKA did not
reverse the α1A-AR-induced inhibition of DNA synthesis.
Therefore, α1A-AR-induced cell cycle arrest, hypertrophy
and differentiation, is independent of the cAMP/PKA
pathway in rat-1 cells. Recently, the cAMP pathway has
been implicated in α1A-AR-induced cell cycle arrest in
CHO cells expressing α1A-ARs [18]. The difference
between these cell lines may be due to the inhibitory effect
of PE on ERK in rat-1 cells [33] vs. PE-induced ERK activa-
tion in CHO cells [18]. In addition, the potential effect of
α1A-AR stimulation on CHO cells hypertrophy and differ-
entiation is not known. During our investigation of the
possible mechanism by which PE induces cell cycle arrest,
we observed that although both PE and FN inhibited DNA
synthesis, these two agents produced remarkably different
morphological changes in rat-1 cells. FN promoted a
change in rat-1 cells to a small, shrinked, round shaped
morphology whereas PE shifted the cells to a hypertro-
phied, enlarged and spindle shaped smooth muscle-like
phenotype. This α1A-AR-induced morphological change
was again independent of cAMP. Differences between PE
and cAMP on different cell functions are reported in Table
3. EGF increases DNA synthesis in rat-1 fibroblasts [22]
and slightly increased protein synthesis (our data). How-
ever, EGF was a far less potent hypertrophic agent than PE
and did not change the morphology of rat-1 cells.
The different effects of α1A-AR stimulation and cAMP on
rat-1 cell hypertrophy and morphology led us to explore
the effects of PE and FN on different cell parameters asso-
ciated with morphological changes, i.e. cell cycle regula-
tors and smooth muscle cell differentiation markers.
Recently, it has been reported that the Cdk inhibitor
p27kip1 mediates angiotensin II-induced cell cycle arrest
and hypertrophy in cultured renal tubular cells [34], and
vascular smooth muscle cells [20] and induces intestinal
epithelial cell differentiation [35]. In the present study,
stimulation of α1A-ARs increased the expression of p27kip1
to a much greater extent than p21cip1/waf1, suggesting an
important role for the former Cdk inhibitor in the action
of α1A-AR stimulation. Interestingly, the time of upregula-
tion of p27kip1 by PE correlated closely with its effect on
inhibition of DNA synthesis, which was maximal at 18 h.
Depletion of p27kip1 prevented both PE-induced upregu-
lation of p27kip1  and reversed PE-induced decrease in
DNA synthesis. Therefore, p27kip1 plays a central role as a
mediator of α1A-AR-induced inhibition of DNA synthesis
and probably hypertrophy and differentiation of rat-1
fibroblasts.
An important finding in the present study was that PE pro-
duced a change in the morphology of rat-1 cells character-
ized by an increase in cell size. Supporting this phenotypic
and hypertrophic change was our demonstration that PE
increased global protein synthesis and the expression of
markers specific to smooth muscle cells such as smooth
muscle actin, caldesmon, and myosin heavy chain. The
protein levels of these smooth muscle cell markers were
found to remain elevated for up to 48 h, consistent with
the PE-induced morphological change that persisted for
the same time period. Although stimulation of α1A-ARs
shifted rat-1 fibroblasts to SMC/myocyte-like phenotype,
it also increased the expression of the helix loop helix
protein MyoD, a skeletal muscle-specific regulatory tran-
scription factor [31]. Surprisingly, PE also caused an
increase in pRb expression to a level similar to p27kip1.
MyoD has been shown to interact with pRb and to pro-
mote muscle gene activation and cell cycle arrest [28,36].
Indeed, pRb has been found to contain a differentiation-
promoting activity that is distinct from its cell-cycle pro-
gression functions [37]. More recent evidence has
indicated an essential role for pRb in promoting func-
tional synergism between MyoD and MEF2 proteins [38].
Although PE increased the expression of MyoD in our
study, the rat-1 cells had a smooth muscle/myocyte-like
Table 3: Comparison of the effects of PE and FN on different cell 
parameters.
Parameter PE FN
cAMP production ↑↑
Protein synthesis ↑↓
DNA synthesis ↓↓
Morphology enlarged; spindle-shaped shrunk; rounded
Differentiation markers ↑↓
Cdk inhibitors ↑↑
The arrows indicate a significant increase or decrease elicited by PE 
or FN in the corresponding cell parameter studied. These agents' 
stimulated cAMP production, decreased basal DNA synthesis, and up-
regulated cyclin-dependent kinase inhibitors. PE and cAMP have 
opposite effects on protein synthesis, cell morphology and smooth 
muscle differentiation markers.BMC Cell Biology 2004, 5:47 http://www.biomedcentral.com/1471-2121/5/47
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phenotype. It has been reported that vascular smooth
muscle cells can spontaneously adopt the skeletal muscle
phenotype [31]. Therefore, it is possible that PE increases
expression of MyoD in rat-1 cells during differentiation
into myocyte-like cells. However, expression of MyoD is
not sufficient for the coordinated program of skeletal
myogenesis in smooth muscle cells [31].
PE-induced hypertrophy and differentiation of rat-1 cells
was also associated with increased levels of cell cycle pro-
teins pRb, cyclin D1, PCNA and Cdk2 that are important
for G1/S phase progression [39]. These data indicate that
stimulation of α1A-ARs promotes the transcriptional/
translational activation of the machinery required for G1/
S cell cycle progression. However, a simultaneous increase
in Cdk inhibitors such as p27kip1 prevented DNA synthe-
sis. Elevation of p27kip1 protein level alone is sufficient for
induction of cell cycle arrest, independent of cyclins or
Cdk level [40]. Surprisingly, PE also increased the protein
level of Cdk4, which is normally not affected by mitogenic
stimuli. Although the Cdk inhibitors bind to cyclin/Cdk
complexes and reduce their activity, their interaction is
probably much more complex [25,26]. Cdk inhibitors
may paradoxically activate these kinases, particularly cyc-
lin D/Cdk4, 6 complexes [26].
The mechanism by which stimulation of the α1A-AR pro-
motes the up-regulation of Cdk inhibitors (p27kip1,
p21cip1/waf1), smooth muscle cell markers, MyoD, and G1/
S transition cell cycle proteins (pRb, cyclin D1, PCNA,
Cdk2/4) leading to inhibition of proliferation and stimu-
lation of hypertrophy and differentiation is not known.
The cAMP/PKA pathway was excluded by our results as
well as the ERK pathway [33]. The phosphatidylinositol 3-
kinase and Akt/PKB pathway, a pro-survival/mitogenic
and hypertrophic pathway is also unlikely to be involved,
because PE does not stimulate this pathway in rat-1 cells
[42]. Recently, a study on the genetic profiling of rat-1
fibroblasts expressing different subtypes of α-AR has
shown that in cells expressing the α1A-AR, epinephrine
(one hour stimulation) increased the gene expression of
IL-6, gp-130 (an IL-6 high affinity receptor and signal
transducer) and STAT-3 (an IL-6 activated transcription
factor) [42]. Moreover, in cells expressing α1A-adrenergic
receptor, epinephrine also increased IL-6 secretion and
STAT-3 Ser727 phosphorylation [42]. Therefore, it is possi-
ble that IL-6, gp130, and/or STAT-3 contributes to the
upregulation of one or more of the cell cycle associated
proteins and smooth muscle cell markers responsible for
the cells arrest, hypertrophy and/or differentiation caused
by α1A-AR activation in rat-1 cells.
With regard to functional significance in vivo, our model
uses a transformed embryonic fibroblast cell line that
expresses high levels of α1A-AR [12]. Therefore, the
relevance of these results to fibroblasts in tissues remains
to be determined. These features in our model may under-
lie the ability of PE to cause expression of SMC markers
and MyoD through α1A-AR.
Conclusions
This study demonstrates that stimulation of α1A-ARs in
rat-1 cells promotes cell cycle arrest by increasing levels of
Cdk inhibitors and promotes hypertrophy and differenti-
ation into a phenotype having the characteristics of
smooth muscle cells by a mechanism independent of
cAMP or EGF. Moreover, cell cycle progression was
blocked at G1/S transition without causing apoptosis, and
this cycle arrest was critical for rat-1 cell hypertrophy and
differentiation. Reducing p27kip1 levels reversed α1A-AR-
promoted inhibition of DNA synthesis. Furthermore, it
shows that cell cycle arrest and differentiation are closely
coordinated processes but temporally separable. Further
studies are underway in our laboratory to characterize the
signaling pathway(s) involved in α1A-AR-induced differ-
entiation of fibroblasts to smooth muscle cells.
Methods
Materials
[Methyl-3H]thymidine (20 Ci/mmol) was purchased
from NEN Life Science Products, Inc. (Boston, MA). L-
[4,5-3H] leucine from Amercham Pharmacia Biotech.
(Piscataway, NJ.). L-phenylephrine hydrochloride, peni-
cillin, streptomycin, prazosin, propranolol, epidermal
growth factor (EGF), and propidium iodide were
obtained from Sigma (St. Louis, MO). Forskolin (FN), 8-
cpt-cAMP and SQ 22536 were purchased from
Calbiochem (La Jolla, CA). 2'-5'dideoxyadenosine and 2'-
deoxyadenosine 3'-monophosphates were purchased
from Biomol (Playmouth Meeting, PA). G418 sulfate
from Invitrogen (Carlsbad, CA). Hanks' balanced salt
solution and fetal bovine serum were from Mediatech,
Inc. (Herndon, VA). Dulbecco's Modified Eagle's Medium
(DMEM) and trypsin/EDTA were obtained from Life
Technologies Inc. (Grand Island, N.Y).
Rat-1 cells and culture conditions
Rat-1 cells transfected with bovine α1A-AR kindly pro-
vided to us by Drs. L. Allen, R. J. Lefkowitz, and M. G.
Caron (Duke University), were maintained in DMEM sup-
plemented with 10% (v/v) fetal bovine serum, 400 µg/ml
G418 sulfate, 50 µg/ml streptomycin and 50 units/ml
penicillin at 37°C in an humid atmosphere (5% CO2,
95% air). Cells were serially passaged upon reaching
confluence, and all experiments were performed on sub-
culture passages 5–15. Prior to all experiments, preconflu-
ent cell cultures were serum-starved for 48 h.BMC Cell Biology 2004, 5:47 http://www.biomedcentral.com/1471-2121/5/47
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Measurement of DNA synthesis
Cells at a density of 150,000 cells/well were seeded in
DMEM containing 10% FBS on 24-well plates until they
reached 80–90% confluency and were serum-deprived for
48 h prior to the addition of agonists. Rat-1 cells, even
after serum-deprivation for 2 days, exhibit a measurable
level of [3H]thymidine incorporation. Inhibition of
[3H]thymidine incorporation was used as a quantitative
measure of reduction in DNA synthesis. Cells were serum-
starved in the presence or absence of agonists for the indi-
cated time period, and [3H]thymidine (0.5 µCi/ml) was
added for the last 4 h of the incubation. This time period
was chosen because it gave the maximum incorporation
of [3H]thymidine into DNA after addition of agonists. The
medium was then removed, and the cells were washed
twice with phosphate-buffered saline and three times with
10% ice-cold trichloroacetic acid. Cells were kept in con-
tact with trichloroacetic acid for 10 min during each wash.
The precipitated material was dissolved in 1 M NaOH
containing 0.1% SDS, and radioactivity was determined
by liquid scintillation spectrometry.
Measurement of protein synthesis
Rat-1 cells were seeded at a density of 150,000 cells/well
in 24-well plates and just prior to confluency were serum-
deprived for 48 h. Cells were rinsed with DMEM and 1
µCi/ml [3H]leucine was added for the last 4 h of each
incubation with or without the indicated concentrations
of the agonists. Cells were fixed and washed three times
with ice-cold trichloroacetic acid (10%). The precipitated
material was solubilized with 0.1 M NaOH and the incor-
porated radioactivity was counted by liquid spectrometry.
Flow cytometry
Flow cytometry studies were performed to determine the
effect of different concentrations of PE on cell cycle
phases. Cells were subjected to flow cytometric DNA anal-
ysis as described [43] with some modifications. Briefly,
rat-1 cells plated on 100 mm dishes were grown in DMEM
containing 10% FBS until they reached 80–90% conflu-
ency. Preconfluent cell cultures were serum-starved for 48
h to stop the mitogenic effect of growth factors. The
medium was aspirated and cells were incubated for 18 h
with different concentrations of PE. Cells were trypsinized
in 1 ml trypsin/EDTA for at least 5 min, and then the reac-
tion was stopped by the addition of 1 ml of serum-con-
taining DMEM. The samples were centrifuged at 1000
rpm for 5 min, washed three times in ice-cold PBS con-
taining 1% bovine serum albumin by centrifugation at
1000 rpm for 5 min each, resuspended in 0.5 ml of the
same solution, and then fixed with 1 ml of 70% ethanol
(-20°C) added dropwise. The fixed cells were stored at
4°C until analyzed. Cells were then washed three times by
centrifuging at 1000 rpm for 10 min and resuspended in
3 ml of the BSA buffer. The pellet was then finally resus-
pended in 1 ml of the BSA buffer to which 100 µg/ml of
RNAse A was added to remove interfering RNA, and 5 µg/
ml propidium iodide was added to stain DNA. Cells were
incubated at 37°C for 10–15 min in the dark to facilitate
staining. The cells were analyzed for DNA content using
an Epics Profile Analyzer (Coulter Electronics) with an
Argon laser emitting at 448 nm. Percentages of cells in
various stages of the cell cycles were determined using a
multi-cycle program (P. Rabinovitch, Phoenix Flow Sys-
tems). At least 10,000 cells per cycle were counted for each
treatment.
Cell viability
Preconfluent cultures were serum-starved for 48 h. Cells
were incubated with different concentrations of PE, FN
and 8-cpt-cAMP for 18 h, trypsinized with 1 ml trypsin/
EDTA for 5 min and centrifuged for 10 min at room
temperature. The pellet was resuspended in 1 ml plain
DMEM. 10 µL of the suspension was mixed with 10 µL of
0.4% trypan blue in a 0.5 ml microtube. The total number
of cells and the number of blue cells and the percentage of
the viable cells in 10 µL of the trypan blue mixture was cal-
culated as follows: % viable cells = [1-(blue cells/total
cells)] × 100.
Morphological study
Rat-1 cells resuspended in culture medium were seeded
on six-well plates (Corning, N.Y.). Preconfluent cells were
serum-deprived for 2 days, pre-incubated with inhibitor
(s) for 30 min, and then stimulated with 5 µM PE and /or
1 µM FN for the indicated time. Cells were rinsed twice in
PBS to remove non-adherent cells and then fixed for 10
min in [1:1] methanol-acetone mixture at room
temperature. Cells were washed once in distilled water
and stained in hematoxylin solution (Sigma, St. Louis,
MO) for 15 min at room temperature. Cells were again
washed three times in water, air dried and were finally
observed under a phase contrast microscope. Images were
captured and saved as TIFF files. For each condition, data
were collected by random observation. Hypertrophic
phenotype was defined as both enlarged, elongated and
spindle-shaped whereas rat-1 fibroblasts are round and/or
polygonal-shaped cells.
Transfection procedures
To determine whether protein kinase A (PKA) mediates
the antiproliferative effect of PE, rat-1 cells were tran-
siently transfected with πLXX-PKI [1-31,24], a plasmid
encoding for the PKA inhibitor, PKI (A generous gift from
Dr. J. Avruch, Massachusetts General Hospital, Boston,
MA), using Lipofectamine Plus (Life Technologies, Inc.,
Grand Island, N.Y.) according to the manufacturer's
instructions. For p27kip1 experiments, phosphorothionate
oligonucleotides (ODN) (Life Technologies, Grand
Island, N.Y.) were used. The antisense ODN sequenceBMC Cell Biology 2004, 5:47 http://www.biomedcentral.com/1471-2121/5/47
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used in the experiments was 5'-CACTCTCACGTTTGA-
CAT-3' (nuc 1–18 of rat p27 kip1); the sense ODN
sequence was 5'-ATGTCAAACGTGAGAGTG. ODN trans-
fection was performed with oligofectamine in Opti-MEM
according to the manufacturer's protocol (Invitrogen,
Carlsbad, CA). Cells were left in the transfection mixture
for 48 h and then incubated for 24 h with or without
agonists and harvested for Western blot, or labeled with
[3H]thymidine to determine DNA synthesis.
Preparation of cell lysates and western blot analysis
Cells were rinsed twice with PBS and lysed in ice-cold lysis
buffer (1% Igepal CA-630, 25 mM HEPES pH 7.5, 50 mM
NaCl, 50 mM NaF, 5 mM EDTA, 10 mg/ml aprotinin, 10
mg/ml leupeptin, and 5 mg/ml pepstatin A, 100 mM
PMSF, 100 mM sodium orthovanadate, and 10 µM oka-
daic acid). Lysates were centrifuged at 4°C for 15 min in a
microfuge at maximum speed, and the supernatant was
collected for Western blot analysis. Equal amounts of pro-
tein were separated on denaturing SDS/polyacrylamide
gel and transferred on nitrocellulose blots (Hybond-ECL;
Amersham Life Sciences Inc., Arlington Heights, IL) by
electrophoresis. Blots were blocked for 1 h in 5% nonfat
dry milk in TBST, washed three times 5 min each in TBST
and then incubated with the indicated specific primary
antibody overnight at 4°C: p27kip1, p21waf1/cip1, pRb (Bio-
source International); caldesmon (smooth muscle),
myosin (smooth muscle), α-smooth muscle actin, β-actin
(Sigma Biosciences); MyoD, cyclin D1, Cdk 2, Cdk 4,
PCNA, lamin A/C or vimentin (Santa Cruz Biotechnol-
ogy). Following incubation, the membranes were washed
three times 10 min each in TBST and incubated with a sec-
ondary antibody coupled to peroxidase for 1 h at room
temperature. Then the membranes were washed three
times 10 min each in TBST. Specific proteins were detected
by enhanced chemiluminescence (ECL; Amersham Life
Sciences Inc.) according to the manufacturer's instructions
and analyzed with an Alpha Innotech Fluorochem imag-
ing system (Packard Canberra). A lysate from cultured
aortic vascular smooth muscle cell (VSMC) was used as a
control for the expression of smooth muscle markers.
Statistical analysis
The basal values of incorporation of [3H]thymidine and/
or leucine were variable in different batches of cells. How-
ever, the effect of various agents on the incorporation of
[3H]thymidine and [3H]leucine in rat-1 cells was consist-
ent within each batch of cells. The results are expressed as
mean ± SEM. The data were analyzed by one-way analysis
of variance; the Newman-Keuls multiple range test was
applied to determine the differences among multiple
groups, the unpaired Student's t-test was applied to deter-
mine the difference between two groups. The null hypoth-
esis was rejected at p < 0.05. The protein level were
estimated by densitometric analysis of the Western blots
and performed on the indicated number of blots using
NIH Image software, and expressed as a percentage of the
control, arbitrarily chosen as 100%.
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